Next Century Growth Investors’s RxSight RXST Stock Holding History

Next Century Growth Investors’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-163,359	Closed	-$4.12M	–	133
2025 Q1	$4.12M	Sell	163,359 -7,540	-4%	-$224K	0.37%	85
2024 Q4	$5.88M	Sell	170,899 -405,554	-70%	-$18.3M	0.44%	80
2024 Q3	$28.5M	Buy	576,453 +48,157	+9%	+$2.47M	2.31%	5
2024 Q2	$31.8M	Buy	528,296 +17,783	+3%	+$1.02M	2.64%	8
2024 Q1	$26.3M	Sell	510,513 -146,508	-22%	-$7.19M	2.29%	12
2023 Q4	$26.5M	Sell	657,021 -90,806	-12%	-$2.66M	2.58%	11
2023 Q3	$20.9M	Sell	747,827 -85,558	-10%	-$2.55M	2.27%	13
2023 Q2	$24M	Sell	833,385 -43,178	-5%	-$960K	2.31%	15
2023 Q1	$14.6M	Buy	876,563 +228,468	+35%	+$3.23M	1.61%	20
2022 Q4	$8.21M	Buy	+648,095	New	+$7.88M	0.99%	41

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Next Century Growth Investors's RXST Position: Q2 2025 in Review

Next Century Growth Investors sold out of RxSight (RXST) in Q2 2025, closing a stake of 163,359 shares — an estimated $4.12M sold.

Next Century Growth Investors first reported a position in RXST in Q4 2022 and held it in 10 quarters. The position peaked at $31.8M in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

Next Century Growth Investors reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
Next Century Growth Investors sold 163,359 RxSight shares in Q2 2025, an estimated $4.12M.
Next Century Growth Investors first reported a position in RxSight in Q4 2022 and held it in 10 quarters.
Next Century Growth Investors's RxSight position peaked at $31.8M in Q2 2024.
174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Next Century Growth Investors's 13F filing for Q2 2025, filed 14 Aug 2025.